1. Home
  2. UXIN vs YDES Comparison

UXIN vs YDES Comparison

Compare UXIN & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uxin Limited ADS

UXIN

Uxin Limited ADS

N/A

Current Price

$3.53

Market Cap

756.6M

ML Signal

N/A

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$6.58

Market Cap

894.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
UXIN
YDES
Founded
2011
2013
Country
China
Taiwan
Employees
N/A
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
756.6M
894.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
UXIN
YDES
Price
$3.53
$6.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
115.6K
11.4K
Earning Date
03-13-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$237.18
N/A
Revenue Next Year
$145.46
N/A
P/E Ratio
$4.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.45
$5.40
52 Week High
$5.40
$25.00

Technical Indicators

Market Signals
Indicator
UXIN
YDES
Relative Strength Index (RSI) 50.10 48.51
Support Level $3.21 N/A
Resistance Level $3.83 $9.46
Average True Range (ATR) 0.19 0.70
MACD -0.01 0.03
Stochastic Oscillator 45.16 77.25

Price Performance

Historical Comparison
UXIN
YDES

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: